🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Bicara Therapeutics Inc.

BCAX Healthcare
$23.41 +$0.3 (1.30%)
Market Cap: $1.53 B
Gurus Holding
1
Popularity Rank
#4665
% of Shares Held
0.04%
Net Activity (Q4 2025)
-$330,120.22

Guru Ownership Trend

Guru Analysis for Bicara Therapeutics Inc. (BCAX)

Bicara Therapeutics Inc. (BCAX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $641,223.31.

Top institutional holders include Paul Tudor Jones.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $330,120.22 net outflow during the quarter.

Recent activity highlights Paul Tudor Jones who increased their stake by 46.2%.

Key Holders

Top 5 by Value

$460,991

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$145,764.78
Total Buy Value
New Buys 0
Additions 1
-$475,885
Total Sell Value
Reductions 0
Sold Out 1

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
1
Net Buyers
1

FAQs for Bicara Therapeutics Inc. (BCAX)

Major holders include Paul Tudor Jones ($460,991). According to the latest reported data, 1 tracked investment managers collectively hold approximately 27,391 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $330,120.22, with 1 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited BCAX. The total reported sell value was $475,885.

Yes, 0 managers opened new positions in BCAX, and 1 increased their existing holdings. The total reported buy value was $145,764.78.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 46.2% 27,391 $460,991 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form